Chuming Tao

Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS)

Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy

A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients

Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma

A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma

Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma

N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma

Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma

Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas